跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,158 条关于
“Praxis Precision”
全部
9,158
临床试验
4,310
药物
105
机构
93
资讯
4,650
去年
Praxis Precision Faces Setback as Essential Tremor Drug Trial Falls Short of Expectations
10个月前
Praxis Precision Medicines Advances Multiple Neurological Programs Following Essential Tremor Success
2年前
Praxis Precision Medicines Sees Positive Analyst Outlook Following Pipeline Progress
去年
Praxis Precision Medicines Stock Surges as Analysts Maintain Strong Buy Ratings for CNS Drug Developer
9个月前
Praxis Precision Medicines Reports Positive EMBOLD Study Results for Relutrigine in Rare Epileptic Encephalopathies
2年前
Relutrigine Shows Promise in Reducing Seizures in SCN2A/SCN8A-DEE Phase 2 Trial
去年
Praxis Precision Medicines Announces Strategic Priorities and Pipeline Milestones for 2025
去年
Praxis Precision's Ulixacaltamide Targets Essential Tremor in Phase 3 Trial
去年
Praxis Precision's Essential Tremor Trial Halted After Disappointing Interim Analysis
去年
FDA Grants Rare Pediatric Disease Designation to Praxis' Relutrigine for Dravet Syndrome
第 1 页,共 465 页
上一页
下一页